TYPE2 DIABETES MELLITUS
Clinical trials for TYPE2 DIABETES MELLITUS explained in plain language.
Never miss a new study
Get alerted when new TYPE2 DIABETES MELLITUS trials appear
Sign up with your email to follow new studies for TYPE2 DIABETES MELLITUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
AI-Powered food app and smart glucose monitor could transform diabetes management
Disease control Recruiting nowThis study tests whether an AI app called SnapD, which recognizes Thai food and estimates nutrition, can help people with type 2 diabetes and overweight improve their blood sugar control. Some participants will also use a continuous glucose monitor (CGM) that tracks sugar levels …
Matched conditions: TYPE2 DIABETES MELLITUS
Phase: NA • Sponsor: Ramathibodi Hospital • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Daily pill aims to tackle weight and diabetes together
Disease control Recruiting nowThis phase 3 study tests aleniglipron, an oral medication taken once daily, for helping adults with obesity or overweight and type 2 diabetes manage their weight over the long term. Participants receive either aleniglipron or a placebo for 76 weeks. The main goal is to see how mu…
Matched conditions: TYPE2 DIABETES MELLITUS
Phase: PHASE3 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New pill for diabetes and kidney disease enters first human tests
Disease control Recruiting nowThis early-stage study tests an experimental oral drug called ONO-3310 in healthy Japanese men and in people with type 2 diabetes who also have chronic kidney disease. The main goal is to check the drug's safety and how the body processes it. Researchers will also measure its eff…
Matched conditions: TYPE2 DIABETES MELLITUS
Phase: PHASE1 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC